ES2103811T3 - Terapia antiviral. - Google Patents

Terapia antiviral.

Info

Publication number
ES2103811T3
ES2103811T3 ES91909492T ES91909492T ES2103811T3 ES 2103811 T3 ES2103811 T3 ES 2103811T3 ES 91909492 T ES91909492 T ES 91909492T ES 91909492 T ES91909492 T ES 91909492T ES 2103811 T3 ES2103811 T3 ES 2103811T3
Authority
ES
Spain
Prior art keywords
animal
antiviral therapy
viral
relates
herpes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91909492T
Other languages
English (en)
Inventor
John J Hooks
Charles H Evans
Barbara Detrick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
US Department of Commerce
Original Assignee
US Department of Health and Human Services
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Department of Commerce filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of ES2103811T3 publication Critical patent/ES2103811T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UN METODO DE TRATAMIENTO DE UNA INFECCION VIRICA DE UN ANIMAL INCLUYE LA ADMINISTRACION DE UNA COMPOSICION QUE CONTIENE LEUCORREGULINA SOLA O EN COMBINACION CON UN AGENTE QUIMIOTERAPEUTICO ANTIVIRICO Y/O UN PORTADOR FARMACEUTICO.
ES91909492T 1990-05-11 1991-05-10 Terapia antiviral. Expired - Lifetime ES2103811T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/521,706 US5368853A (en) 1990-05-11 1990-05-11 Leukoregulin anti-viral therapy

Publications (1)

Publication Number Publication Date
ES2103811T3 true ES2103811T3 (es) 1997-10-01

Family

ID=24077805

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91909492T Expired - Lifetime ES2103811T3 (es) 1990-05-11 1991-05-10 Terapia antiviral.

Country Status (11)

Country Link
US (2) US5368853A (es)
EP (1) EP0531341B1 (es)
JP (1) JPH0768136B2 (es)
AT (1) ATE155795T1 (es)
AU (1) AU644661B2 (es)
CA (1) CA2082270C (es)
DE (1) DE69126977T2 (es)
DK (1) DK0531341T3 (es)
ES (1) ES2103811T3 (es)
GR (1) GR3024236T3 (es)
WO (1) WO1991018014A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5368853A (en) * 1990-05-11 1994-11-29 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Leukoregulin anti-viral therapy
CA2420944A1 (en) 2000-08-30 2002-03-07 Chemocentryx, Inc. Inhibition of cmv infection and dissemination
WO2002062296A2 (en) * 2001-02-02 2002-08-15 Chemocentryx, Inc. Methods and compositions useful for stimulating an immune response
US7172085B2 (en) * 2001-12-04 2007-02-06 Beaudette Susan A Squeezable, fillable feeding device
WO2018035046A1 (en) 2016-08-15 2018-02-22 President And Fellows Of Harvard College Treating infections using idsd from proteus mirabilis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
US5082657A (en) * 1984-04-13 1992-01-21 Akzo N.V. Leukoregulin, an antitumor lymphokine, and its therapeutic uses
US4849506A (en) * 1984-04-13 1989-07-18 Akzo N.V. Leukoregulin, an antitumor lymphokine, and its therapeutic uses
EP0230574A3 (en) * 1986-01-31 1989-03-22 Yale University Pharmaceutical compositions against infections caused by lav/htlv iii virus and the use thereof
US5368853A (en) * 1990-05-11 1994-11-29 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Leukoregulin anti-viral therapy

Also Published As

Publication number Publication date
EP0531341A1 (en) 1993-03-17
GR3024236T3 (en) 1997-10-31
US5368853A (en) 1994-11-29
JPH0768136B2 (ja) 1995-07-26
ATE155795T1 (de) 1997-08-15
DE69126977T2 (de) 1997-11-27
EP0531341A4 (en) 1993-07-28
DE69126977D1 (de) 1997-08-28
CA2082270A1 (en) 1991-11-12
EP0531341B1 (en) 1997-07-23
JPH05508834A (ja) 1993-12-09
US5529771A (en) 1996-06-25
WO1991018014A1 (en) 1991-11-28
CA2082270C (en) 1996-12-10
AU644661B2 (en) 1993-12-16
AU7873391A (en) 1991-12-10
DK0531341T3 (da) 1997-09-22

Similar Documents

Publication Publication Date Title
MY107843A (en) Anti-viral compounds.
ZA851765B (en) Anti-viral pharmaceutical preparations and methods for their use
DK486588D0 (da) Konjungater af cytokininer med immunglobuliner
PT911033E (pt) Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral
ATE185483T1 (de) Antivirale nucleosidkombination
YU7296A (sh) Farmaceutska kompozicija koja sadrži kombinaciju jedne protivvirusne supstance i jednog protivzapaljenskog glukokortikoida
TR199903053T2 (xx) Benzimidazol t�revleri.
RU94022480A (ru) Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
ES2103811T3 (es) Terapia antiviral.
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
LV10191A (lv) Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai
DE68900760D1 (de) Virushemmende nukleosidmischung.
IL111338A0 (en) Pharmaceutical or veterinary compositions comprising flavin derivatives for the treatment of viral infections and their preparation
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
MX9303985A (es) Nucleosidos terapeuticos.
DK0459176T3 (da) Oligophosphater med antiviral virkning
DE68914809D1 (de) Antivirale Wirkstoffe.
MX9307639A (es) Metodo para tratar infecciones virales con terapia conjuntiva con compuestos similares al aciclovir y un analogo de nucleosido 2'-viril substituido.
SU1565027A1 (ru) Инактиватор вируса западного нила

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 531341

Country of ref document: ES